MMP1 and breast carcinoma: Among ECM components, integrins contribute to progression in many cancers, including breast cancers and down-regulation of surface alpha4beta1-receptor during oncogenic transformation critical for the establishment of the alpha5beta1-receptor-induced, MMP1–dependent invasive phenotype of breast cancer cells [14].